Hydromorphone 3mg Rectal Supp

Manufacturer PERRIGO Active Ingredient Hydromorphone Suppository(hye droe MOR fone) Pronunciation hye droe MOR fone
WARNING: This is an opioid drug. Opioid drugs can put you at risk for drug use disorder. These can lead to overdose and death. You will be watched closely while taking this drug.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing. Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life-threatening if not treated. @ COMMON USES: It is used to manage pain when non- opioid pain drugs do not treat your pain well enough or you cannot take them.
🏷️
Drug Class
Opioid analgesic
🧬
Pharmacologic Class
Opioid agonist
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
May 1942
βš–οΈ
DEA Schedule
Schedule II

Overview

ℹ️

What is this medicine?

Hydromorphone is a strong pain medicine, similar to morphine, that works in your brain to change how your body feels and responds to pain. This medicine comes as a suppository that you insert into your rectum (back passage) to relieve severe pain.
πŸ“‹

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Insert the suppository rectally, and make sure to wash your hands before and after handling it. If the suppository is soft, you can chill it in the refrigerator or run it under cold water to firm it up. To insert the suppository, lie on your side and remove the foil wrapper. Gently push the suppository into your rectum, pointed end first, and avoid handling it excessively. Wetting the suppository before insertion can make it easier to use.

Storing and Disposing of Your Medication

Store the suppositories in the refrigerator, but do not freeze them. Keep the medication in a secure location, out of the reach of children and pets, and consider using a locked box or area to prevent unauthorized access. When you're finished with the medication or it's expired, dispose of it properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your pharmacist. Check with your pharmacist for guidance on the best way to dispose of your medication, and look into local drug take-back programs.

Missing a Dose

If you take this medication on a regular schedule, take the missed dose as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses. If you take this medication as needed, follow your doctor's instructions and do not take it more frequently than recommended.
πŸ’‘

Lifestyle & Tips

  • Do not drive or operate heavy machinery until you know how this medicine affects you, as it can cause drowsiness and dizziness.
  • Avoid alcohol and other medications that can make you sleepy (like tranquilizers, sleeping pills, or other pain medications) while taking hydromorphone, as this can lead to dangerous breathing problems or extreme drowsiness.
  • To prevent constipation, drink plenty of fluids, eat fiber-rich foods, and consider using a stool softener or laxative as recommended by your doctor.
  • Store this medicine securely away from children and pets, as accidental ingestion can be fatal.
  • Do not share this medication with anyone else, as it is a controlled substance and can be dangerous for others.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 3 mg rectally every 3 to 4 hours as needed for pain
Dose Range: 1 - 6 mg

Condition-Specific Dosing:

opioid_naive: Initial dose should be lower (e.g., 1-2 mg) and titrated slowly.
opioid_tolerant: Dose should be individualized based on previous opioid use and pain severity, often higher than opioid-naive patients.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for routine use; use with extreme caution and individualized dosing if necessary, typically in hospice or palliative care.
Adolescent: Not established for routine use; use with extreme caution and individualized dosing if necessary, typically in hospice or palliative care.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment, but monitor for increased effects.
Moderate: Reduce initial dose by 25-50% and titrate slowly; monitor closely for respiratory depression and sedation.
Severe: Reduce initial dose by 50-75% and extend dosing interval; monitor closely for respiratory depression and sedation.
Dialysis: Not dialyzable to a significant extent. Administer after dialysis. Reduce dose and extend interval.

Hepatic Impairment:

Mild: No specific adjustment, but monitor for increased effects.
Moderate: Reduce initial dose by 25-50% and titrate slowly; monitor closely for respiratory depression and sedation.
Severe: Reduce initial dose by 50-75% and extend dosing interval; monitor closely for respiratory depression and sedation.

Pharmacology

πŸ”¬

Mechanism of Action

Hydromorphone is a full opioid agonist that binds to and activates mu-opioid receptors in the central nervous system (CNS), primarily in the brain and spinal cord. This binding leads to inhibition of ascending pain pathways, altering the perception of and response to pain. It also produces generalized CNS depression, including respiratory depression, sedation, and antitussive effects.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Variable (rectal bioavailability can range from 30-60% due to incomplete absorption and first-pass metabolism in the rectal mucosa/liver)
Tmax: Approximately 30-90 minutes (rectal)
FoodEffect: Not applicable for rectal administration

Distribution:

Vd: Approximately 4 L/kg
ProteinBinding: Approximately 8-19%
CnssPenetration: Yes

Elimination:

HalfLife: Approximately 2-4 hours
Clearance: Approximately 1.9 L/min
ExcretionRoute: Renal (primarily as glucuronide conjugates)
Unchanged: <10%
⏱️

Pharmacodynamics

OnsetOfAction: 15-30 minutes (rectal)
PeakEffect: 30-90 minutes (rectal)
DurationOfAction: 3-5 hours (rectal)

Safety & Warnings

⚠️

BLACK BOX WARNING

RISK OF ADDICTION, ABUSE, AND MISUSE; RESPIRATORY DEPRESSION; NEONATAL OPIOID WITHDRAWAL SYNDROME; ACCIDENTAL INGESTION; and CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS. Hydromorphone exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing hydromorphone, and monitor all patients regularly for the development of these behaviors and conditions. Serious, life-threatening, or fatal respiratory depression may occur. Neonatal opioid withdrawal syndrome may occur with prolonged maternal use during pregnancy. Accidental ingestion of hydromorphone, especially by children, can result in a fatal overdose. Concomitant use with benzodiazepines or other CNS depressants may result in profound sedation, respiratory depression, coma, and death.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or fainting
Confusion
Severe constipation or stomach pain, which may indicate a serious bowel problem
Abnormal heartbeat (fast, slow, or irregular)
Breathing difficulties, including:
+ Trouble breathing
+ Slow or shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Hallucinations (seeing or hearing things that are not there)
Mood changes
Seizures
Shakiness
Difficulty urinating
Uncontrolled eye movements
Trouble controlling body movements
Changes in vision
Chest pain or pressure
Balance problems
Memory problems or loss
Thoughts of self-harm or suicide
Swelling in the arms or legs

Serotonin Syndrome: A Potentially Life-Threatening Condition

If you take this medication with certain other drugs, you may be at risk for serotonin syndrome, a severe and potentially deadly condition. Seek medical help immediately if you experience:

Agitation
Balance problems
Confusion
Hallucinations
Fever
Abnormal heartbeat (fast or irregular)
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, nausea, or vomiting
Severe headache

Long-Term Use and Hormonal Changes

Prolonged use of opioid medications like this one may lead to decreased sex hormone levels. If you experience any of the following symptoms, contact your doctor:

Decreased interest in sex
Fertility problems
Irregular or absent menstrual periods
Ejaculation problems

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it's essential to be aware of the following possible side effects:

Constipation
Diarrhea
Stomach pain
Nausea or vomiting
Decreased appetite
Dizziness
Drowsiness
Fatigue
Weakness
Dry mouth
Flushing
Excessive sweating
Headache
Itching
Sleep disturbances

If any of these side effects bother you or persist, contact your doctor for guidance. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Slow or shallow breathing (less than 10 breaths per minute)
  • Extreme drowsiness or difficulty waking up
  • Bluish lips or fingernails
  • Severe dizziness or lightheadedness
  • Confusion
  • Pinpoint pupils
  • Severe constipation or inability to have a bowel movement
  • Signs of an allergic reaction (rash, itching, swelling of face/tongue/throat, severe dizziness, trouble breathing)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, such as:
+ Respiratory problems, including asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel obstruction or narrowing
Recent use (within the last 14 days) of specific medications for depression or Parkinson's disease, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may increase the risk of severely high blood pressure
Current use of certain medications, such as buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine whether it is safe to take this medication with your existing treatments and health status. Never start, stop, or adjust the dosage of any medication without consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you understand how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position, and exercise caution when climbing stairs.

Dosage and Administration
Do not exceed the dosage prescribed by your doctor. Taking more than the recommended dose, or taking it more frequently or for a longer period than directed, may increase the risk of severe side effects.

Interactions with Other Medications
Before taking this medication with other strong pain medications or using a pain patch, consult your doctor. If you experience worsening pain, increased sensitivity to pain, or new pain, contact your doctor immediately. Do not take more than the prescribed dose.

Monitoring and Maintenance
If you are taking this medication long-term, your doctor may recommend regular blood tests to monitor your condition.

Allergies and Sensitivities
If you are allergic to sulfites, discuss this with your doctor, as some products may contain sulfites.

Alcohol Interactions
Do not consume alcohol or products containing alcohol while taking this medication, as this may lead to unsafe and potentially fatal effects.

Tolerance and Dependence
Prolonged or high-dose use of this medication may lead to tolerance, reducing its effectiveness. If you experience decreased efficacy, contact your doctor. Do not take more than the prescribed dose. Long-term or regular use of opioid medications like this one may cause dependence. If you need to reduce the dose or stop taking this medication, consult your doctor to minimize the risk of withdrawal or other severe problems.

Seizure Risk
This medication may increase the risk of seizures, particularly in individuals with a history of seizure disorders. Discuss your risk with your doctor.

Adrenal Gland Problems
Taking an opioid medication like this one may lead to a rare but severe adrenal gland problem. Seek medical attention immediately if you experience extreme fatigue, weakness, fainting, severe dizziness, nausea, vomiting, or decreased appetite.

Special Considerations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Breastfeeding
If you are breastfeeding, inform your doctor, as this medication passes into breast milk and may harm your baby. Seek medical help immediately if your baby appears excessively sleepy, limp, or has difficulty breathing.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Slowed or stopped breathing
  • Extreme drowsiness or unresponsiveness
  • Pinpoint pupils
  • Cold, clammy skin
  • Limp muscles
  • Bluish discoloration of lips and fingernails
  • Loss of consciousness
  • Coma

What to Do:

Seek immediate emergency medical attention. Call 911 or your local emergency number. Administer naloxone if available and trained to do so. Call 1-800-222-1222 (Poison Control Center) for further guidance.

Drug Interactions

🚫

Contraindicated Interactions

  • Concomitant use with benzodiazepines or other CNS depressants in patients for whom alternatives are inadequate (Black Box Warning)
  • Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of MAOI therapy (risk of serotonin syndrome or severe respiratory depression)
πŸ”΄

Major Interactions

  • Other CNS depressants (e.g., alcohol, sedatives, hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, phenothiazines, other opioids) - increased risk of respiratory depression, profound sedation, coma, and death.
  • Mixed agonist/antagonist opioids (e.g., pentazocine, nalbuphine, butorphanol) - may reduce analgesic effect and/or precipitate withdrawal symptoms.
  • Anticholinergic drugs - increased risk of urinary retention and/or severe constipation.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans) - risk of serotonin syndrome.
🟑

Moderate Interactions

  • Diuretics - opioids can reduce the efficacy of diuretics by causing release of antidiuretic hormone.
  • Antihypertensives - additive hypotensive effects.
  • Drugs that affect gastric emptying (e.g., metoclopramide) - may alter absorption of oral opioids (less relevant for rectal).
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Pain assessment (intensity, character, location)

Rationale: To establish baseline pain level and guide initial dosing.

Timing: Prior to initiation of therapy

Respiratory rate and depth

Rationale: To assess baseline respiratory function and identify risk for respiratory depression.

Timing: Prior to initiation of therapy

Level of consciousness/sedation

Rationale: To assess baseline mental status and identify risk for excessive sedation.

Timing: Prior to initiation of therapy

Bowel function

Rationale: To assess baseline bowel habits and anticipate opioid-induced constipation.

Timing: Prior to initiation of therapy

πŸ“Š

Routine Monitoring

Pain assessment

Frequency: Regularly, especially during dose titration and with changes in pain severity (e.g., every 3-4 hours initially, then as needed)

Target: Acceptable pain level as defined by patient and clinician

Action Threshold: Uncontrolled pain requires dose adjustment or alternative therapy; excessive pain relief/sedation requires dose reduction.

Respiratory rate and depth

Frequency: Frequently during initiation and dose titration (e.g., every 15-30 minutes for first hour, then hourly for several hours), then periodically as clinically indicated.

Target: Typically >10-12 breaths/min, regular rhythm

Action Threshold: <10 breaths/min, shallow breathing, or signs of hypoventilation require immediate intervention (e.g., naloxone, respiratory support).

Level of consciousness/sedation (e.g., Pasero Opioid-Induced Sedation Scale)

Frequency: Frequently during initiation and dose titration, then periodically as clinically indicated.

Target: Alert or mildly drowsy, easily aroused

Action Threshold: Difficult to arouse or unarousable requires immediate intervention (e.g., naloxone, respiratory support).

Bowel function

Frequency: Daily

Target: Regular bowel movements (e.g., every 1-2 days)

Action Threshold: Constipation (no bowel movement for >2-3 days) requires laxative intervention.

πŸ‘οΈ

Symptom Monitoring

  • Respiratory depression (slow, shallow breathing)
  • Excessive sedation/drowsiness
  • Dizziness
  • Nausea and vomiting
  • Constipation
  • Pruritus (itching)
  • Urinary retention
  • Hypotension
  • Signs of opioid withdrawal (if abruptly discontinued)

Special Patient Groups

🀰

Pregnancy

Use during pregnancy is generally not recommended due to the risk of neonatal opioid withdrawal syndrome (NOWS) and potential for respiratory depression in the neonate. Benefits must outweigh risks.

Trimester-Specific Risks:

First Trimester: Limited data, but potential for congenital malformations with opioid use in early pregnancy is a concern, though not definitively established for hydromorphone.
Second Trimester: Risk of NOWS increases with prolonged use.
Third Trimester: High risk of NOWS if used chronically. Risk of respiratory depression in the neonate if used close to delivery.
🀱

Lactation

Hydromorphone is excreted into breast milk. While levels are generally low, there is a risk of sedation, respiratory depression, and withdrawal symptoms in the infant. Use with caution, monitor infant closely, or consider alternative analgesics.

Infant Risk: L3 (Moderately safe - monitor infant for sedation, poor feeding, respiratory depression, and withdrawal symptoms if drug is discontinued).
πŸ‘Ά

Pediatric Use

Safety and efficacy in pediatric patients have not been established for routine use of rectal suppositories. Use is generally limited to severe, acute pain in opioid-tolerant children under strict medical supervision, often in palliative care settings. Dosing must be highly individualized and carefully titrated.

πŸ‘΄

Geriatric Use

Elderly patients may be more sensitive to the analgesic and adverse effects of opioids, particularly respiratory depression. Start with lower doses and titrate slowly. Monitor closely for sedation, respiratory depression, and constipation. Renal and hepatic impairment are more common in this population, requiring dose adjustments.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Rectal bioavailability of hydromorphone can be variable, leading to unpredictable absorption. This makes dose titration challenging and may require careful monitoring.
  • Hydromorphone is a potent opioid; 3 mg rectal is roughly equivalent to 15-20 mg oral morphine in terms of analgesic effect, but individual patient response varies.
  • Due to the risk of respiratory depression, especially with concomitant CNS depressants, ensure patients and caregivers are educated on signs of overdose and have naloxone readily available if appropriate.
  • Opioid-induced constipation is a common and often severe side effect; proactive bowel regimen (stool softener + stimulant laxative) should be initiated concurrently with opioid therapy.
  • Hydromorphone-3-glucuronide (H3G), a metabolite, can accumulate in renal impairment and may cause neuroexcitatory symptoms (e.g., myoclonus, hyperalgesia, delirium), even if the parent drug levels are not excessively high.
  • This formulation is less commonly used than oral or IV hydromorphone and may be reserved for situations where oral intake is not possible or IV access is difficult.
πŸ”„

Alternative Therapies

  • Other strong opioid agonists (e.g., morphine, oxycodone, fentanyl, oxymorphone)
  • Non-opioid analgesics (e.g., NSAIDs, acetaminophen) for mild to moderate pain or as adjuncts
  • Adjuvant analgesics (e.g., gabapentin, pregabalin for neuropathic pain; antidepressants for chronic pain)
  • Regional anesthesia or nerve blocks
  • Non-pharmacological pain management (e.g., physical therapy, acupuncture, cognitive behavioral therapy)
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 10 suppositories
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (requires prior authorization or step therapy for some plans)
πŸ“š

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed to someone else.

This medication is accompanied by a Medication Guide, which provides crucial information about its safe and effective use. It is essential to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider for clarification.

In the event of an overdose, a medication called naloxone can be administered to help counteract the effects. Discuss the availability and use of naloxone with your doctor or pharmacist. If an overdose is suspected, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide detailed information about the overdose, including the substance taken, the amount, and the time it occurred.

In case of a suspected overdose, contact your local poison control center or seek emergency medical care right away. When reporting the incident, be prepared to provide the necessary information, including the substance involved, the quantity taken, and the time of the incident.